Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Now accepting nominations for the Fierce Innovation Awards - Submit your application today
drug approvals
Pharma
Regulatory tracker: Akeso's ivonescimab wins key nod in China
Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Angus Liu
,
Kevin Dunleavy
,
Fraiser Kansteiner
Aug 12, 2026 9:13am
FDA approves Otsuka’s first-in-class ADHD drug Simtriyo
Jul 27, 2026 12:42pm
Nuvalent deal delivers GSK’s first-ever lung cancer approval
Jul 22, 2026 3:15pm
Fierce Biotech
FDA halts release of new drug rejection letters
Jul 8, 2026 1:33pm
Regulatory tracker: FDA starts review of Sandoz's generic tirzepatide
Jun 29, 2026 10:38am
CDER chief Høeg and CBER's Szarama exiting FDA posts
May 15, 2026 1:44pm